STOCK TITAN

[6-K] iHuman Inc. Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K
Analyzing...
Positive
  • None.
Negative
  • None.

 

 

UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION 

Washington, D.C. 20549

 

 

 

FORM 6-K

 

 

 

REPORT OF FOREIGN PRIVATE ISSUER 

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER 

THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of September 2025

 

Commission File Number: 001-39591

 

 

 

iHuman Inc. 

(Registrant’s Name)

 

 

 

Tower 306,
No. 86 Beiyuan Road
Chaoyang District, Beijing 100101

People’s Republic of China 

(Address of Principal Executive Offices)

 

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

 

Form 20-F x     Form 40-F ¨

 

 

 

 

EXHIBIT INDEX

 

Exhibit No.   Description
99.1   Press Release

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  iHuman Inc.
       
  By : /s/ Vivien Weiwei Wang
  Name : Vivien Weiwei Wang
  Title : Director and Chief Financial Officer

 

Date: September 18, 2025

 

 

Ihuman Inc

NYSE:IH

IH Rankings

IH Latest News

IH Latest SEC Filings

IH Stock Data

152.50M
22.72M
0.79%
Education & Training Services
Consumer Defensive
Link
China
Beijing